Coloplast A/S (CLPBY) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CLPBY Stock Alerts $12.22 -0.06 (-0.49%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10 at 11:43 PM | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Short Interest Up 504.6% in AprilColoplast A/S (OTCMKTS:CLPBY - Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 92,500 shares, a growth of 504.6% from the April 15th total of 15,300 shares. Based on an average daily volume of 189,400 shares, the days-to-cover ratio is currently 0.5 days.March 1, 2024 | globenewswire.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsFebruary 28, 2024 | globenewswire.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsFebruary 23, 2024 | finance.yahoo.comColoplast A/S (CLPBY)February 12, 2024 | finance.yahoo.comColoplast A/S: Coloplast Earnings: Underlying Demand Remains Strong, but Medicare Fraudsters Could Hurt U.S. GrowthFebruary 9, 2024 | finance.yahoo.comColoplast A/S - Allocation of Share OptionsFebruary 9, 2024 | globenewswire.comColoplast A/S - Allocation of Share OptionsFebruary 9, 2024 | finance.yahoo.comColoplast A/S - Interim Financial Report, Q1 2023/24February 9, 2024 | finance.yahoo.comColoplast launches Peristeen® Light for people with bowel disordersFebruary 7, 2024 | morningstar.comColoplast A/S ADRJanuary 31, 2024 | finance.yahoo.comColoplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the USJanuary 11, 2024 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Short Interest UpdateColoplast A/S (OTCMKTS:CLPBY - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 13,300 shares, an increase of 923.1% from the December 15th total of 1,300 shares. Based on an average trading volume of 102,600 shares, the short-interest ratio is currently 0.1 days.December 7, 2023 | msn.comColoplast A/S goes ex-dividend tomorrowNovember 14, 2023 | finance.yahoo.comColoplast A/S - Notice of Annual General Meeting 2023November 9, 2023 | finance.yahoo.comColoplast A/S: Coloplast Earnings: Revenue Growth Remains Solid, but Margin Drag Likely to Last Into 2024September 23, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Receives Consensus Rating of "Hold" from AnalystsColoplast A/S (OTCMKTS:CLPBY - Get Free Report) has earned an average rating of "Hold" from the seven ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy ratingSeptember 1, 2023 | finance.yahoo.comColoplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completedAugust 18, 2023 | finance.yahoo.comMajor shareholder notificationAugust 17, 2023 | finance.yahoo.comColoplast A/S - Announcement no. 04/2023 - Interim Financial Report, 9M 2022/2023August 4, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Given Consensus Recommendation of "Hold" by BrokeragesColoplast A/S (OTCMKTS:CLPBY - Get Free Report) has been given a consensus rating of "Hold" by the seven analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a bJuly 10, 2023 | marketbeat.comDNB Markets Upgrades Coloplast A/S (OTCMKTS:CLPBY) to "Buy"DNB Markets raised Coloplast A/S from a "hold" rating to a "buy" rating in a research report on Monday.July 10, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Given Consensus Recommendation of "Hold" by AnalystsShares of Coloplast A/S (OTCMKTS:CLPBY - Free Report) have been given an average recommendation of "Hold" by the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold ratJuly 7, 2023 | finance.yahoo.comColoplast A/S - Announcement no. 03/2023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectationsMay 21, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Given Average Recommendation of "Hold" by BrokeragesColoplast A/S (OTCMKTS:CLPBY - Get Rating) has been assigned an average recommendation of "Hold" from the seven ratings firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommeMay 19, 2023 | seekingalpha.comCLPBY Coloplast A/SMay 13, 2023 | msn.comColoplast AS - Class B (CLPBF) Declares $5.00 DividendMay 12, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Stock Rating Lowered by JPMorgan Chase & Co.JPMorgan Chase & Co. cut Coloplast A/S from a "neutral" rating to an "underweight" rating in a research note on Friday.May 11, 2023 | finance.yahoo.comColoplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23May 7, 2023 | cbsnews.comSam's Club May 2023 membership deal: Get one year of discounted gas, food and more for $35April 28, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Short Interest Up 118.5% in AprilColoplast A/S (OTCMKTS:CLPBY - Get Rating) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 27,100 shares, a growth of 118.5% from the March 31st total of 12,400 shares. Based on an average daily volume of 72,200 shares, the short-interest ratio is presently 0.4 days.April 24, 2023 | finance.yahoo.comNew clinical study demonstrates significant improvement in pulmonary health and related symptoms when using Provox® Life™April 5, 2023 | benzinga.comShort Volatility Alert: ColoplastMarch 28, 2023 | cbsnews.comSam's Club March membership deal: Get one year of discounted gas, groceries and more for $25March 10, 2023 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Short Interest Down 98.9% in FebruaryColoplast A/S (OTCMKTS:CLPBY - Get Rating) saw a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 400 shares, a drop of 98.9% from the February 13th total of 35,300 shares. Based on an average trading volume of 227,000 shares, the days-to-cover ratio is currently 0.0 days.February 25, 2023 | finance.yahoo.comColoplast A/S: Coloplast Introduces Next-Generation Catheter; No Change to Our Fair Value EstimateDecember 1, 2022 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Announces Dividend of $0.13Coloplast A/S (OTCMKTS:CLPBY) declared a dividend on Thursday, December 1st. Investors of record on Monday, December 5th will be paid a dividend of 0.1349 per share on Friday, December 16th. This represents a yield of 1.53%. The ex-dividend date is Friday, December 2nd. This is a positive change from Coloplast A/S's previous dividend of $0.05.November 28, 2022 | marketbeat.comShort Interest in Coloplast A/S (OTCMKTS:CLPBY) Rises By 9,000.0%Coloplast A/S (OTCMKTS:CLPBY - Get Rating) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 81,900 shares, a growth of 9,000.0% from the October 31st total of 900 shares. Based on an average daily volume of 234,700 shares, the days-to-cover ratio is currently 0.3 days.November 22, 2022 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Price Target Increased to 835.00 by Analysts at BarclaysBarclays lifted their price target on shares of Coloplast A/S from 780.00 to 835.00 and gave the stock an "underweight" rating in a report on Tuesday.November 18, 2022 | finance.yahoo.comColoplast Launches New Catheter in the U.S.November 15, 2022 | finance.yahoo.comColoplast appoints new President of its global Interventional Urology businessNovember 13, 2022 | marketbeat.comShort Interest in Coloplast A/S (OTCMKTS:CLPBY) Decreases By 30.8%Coloplast A/S (OTCMKTS:CLPBY - Get Rating) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 900 shares, a drop of 30.8% from the October 15th total of 1,300 shares. Based on an average daily volume of 206,400 shares, the days-to-cover ratio is currently 0.0 days.November 10, 2022 | finance.yahoo.comColoplast enters into Power Purchase Agreement with Better EnergyNovember 9, 2022 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Price Target Lowered to 1,045.00 at Credit Suisse GroupCredit Suisse Group decreased their price objective on Coloplast A/S from 1,100.00 to 1,045.00 in a report on Wednesday.November 8, 2022 | finance.yahoo.comColoplast A/S - Announcement no. 12/2022 - Notice of Annual General MeetingNovember 7, 2022 | finance.yahoo.comColoplast A/S - Announcement no. 10/2022 - Annual Report 2021/22 & Remuneration Report 2021/22November 7, 2022 | finance.yahoo.comColoplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22November 7, 2022 | finance.yahoo.comColoplast A/S Announcement no. 9/2022 - Full-Year Financial Results 2021/22October 18, 2022 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Now Covered by Analysts at Morgan StanleyOctober 13, 2022 | marketbeat.comShort Interest in Coloplast A/S (OTCMKTS:CLPBY) Declines By 44.7%Coloplast A/S (OTCMKTS:CLPBY - Get Rating) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 42,600 shares, a drop of 44.7% from the September 15th total of 77,100 shares. Based on an average daily trading volume, of 324,200 shares, the days-to-cover ratio is currently 0.1 days.October 6, 2022 | finance.yahoo.comColoplast launches Saffron™ Fixation System for Prolapse Repair Get Coloplast A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. CLPBY Media Mentions By Week CLPBY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPBY News Sentiment▼-0.010.57▲Average Medical News Sentiment CLPBY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPBY Articles This Week▼40▲CLPBY Articles Average Week Get Coloplast A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 1933 Industries News 4Front Ventures News AB Science News Aclarion News Acreage News Acreage News ADM Tronics Unlimited News Aleafia Health News Algernon Pharmaceuticals News Alibaba Health Information Technology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CLPBY) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
